Goldman Sachs downgrades Nike stock rating to sell on market share concerns

Goldman Sachs downgraded Nike to Sell from Neutral and cut its price target to $27.50 from $49.00; Nike was trading at $33.96, down more than 50% over the past year. Nike guided to a high-single-digit revenue decline in fiscal 2027, with Goldman citing sportswear market-share pressure, further weakness in China, and revenue pressure through FY28; the Pace restructuring plan is expected to provide little help until FY29. Analyst views remain mixed, including Freedom Broker’s upgrade to Buy, while several other firms maintained cautious ratings or lowered targets.

Analysis

The key risk is not simply weak demand; it is whether Nike can still turn brand scale into distribution and product advantages as demand fragments. A narrower set of sportswear bets may improve focus, but it can also weaken purchasing leverage, marketing efficiency and shelf-space breadth before any turnaround benefits arrive. That creates a second-order risk for contract manufacturers exposed to Nike volumes; challenger growth could offset it, but only if those brands scale production without forcing supplier pricing down.

Near term, the stated 52-week low is a useful sentiment trigger, not proof of fundamental value. Over 1–3 months, watch China sell-through, wholesale orders and inventory/discounting: stabilization would challenge the downgrade, while further deterioration would support estimates moving lower. Over 6–18 months, the strategic test is whether performance-product strength can offset a broader sportswear mix and whether the restructuring produces measurable sales or margin improvement before FY29. A management reorganization alone is not evidence of recovery.

Contrarian view: after a steep share-price decline and a lower forecast base, another downgrade may have less incremental impact than evidence of stabilization. The reported gross-margin and EPS resilience alongside performance growth argues against treating all Nike categories as equally impaired. Conversely, the article’s “undervalued” Fair Value assertion is not a thesis without its assumptions; earnings revisions and revenue trajectory matter more than that label.

Key Decisions for Investors

• Do not chase an outright short solely on the downgrade. Consider a small, tactical NKE short only on a confirmed break below the cited $31.97 52-week low, with a defined loss limit; a sustained reclaim of that level alongside improving China or wholesale indicators would weaken the setup.
• For a relative-value expression, evaluate short NKE against long a performance-focused footwear peer such as On Running, sized for the risk that peer valuation or a product-cycle reversal dominates the operating thesis. Verify current relative valuation and earnings revisions before entry.
• Over the next 1–3 months, track China sell-through, wholesale order trends, inventory and discounting, and performance-category growth. If China stabilizes and Nike holds margins despite lower sales, cover or avoid the short; if sales weakness broadens and guidance is cut again, the downside thesis gains confirmation.
• Treat supplier spillovers as a watch item, not a stand-alone trade: verify contract manufacturers’ customer concentration and order commentary before expressing a view, since challenger production may partly replace Nike volumes.